Current Scheduling Status
None
Year(s) and type of review / ECDD meetings
Drug Class
Recommendation (from TRS)
ECDD Technical summary
2,5-Dimethoxy-4-ethylamphetamine has been reported to have a hallucinogenic effect in man. In studies in the rat, this compound has been discriminated as hallucinogen-like, but there is some evidence that it may-have a profile of pharmacological action different from that typical of hallucinogens in this series. No toxicological or pharmacokinetic data are available.
It is not self-administered by baboons. No data are available on its clinical abuse liability, on the nature or magnitude of associated public health or social problems, or on the epidemiology of its use or abuse. The drug is under national control in four countries. There is no known therapeutic use and no data on production. There is only one minor report of illicit trafficking. On the basis of the data outlined above, it was the consensus of the Expert Committee that 2,5-dimethoxy-4-ethylamphetamine met the criteria in article 2, paragraph 4, for control under the Convention on Psychotropic Substances. Since the substance has no therapeutic use, the Expert Committee recommended that it be placed in Schedule I of the Convention.
2,5-Dimethoxy-4-ethylamphetamine has been reported to have a hallucinogenic effect in man. In studies in the rat, this compound has been discriminated as hallucinogen-like, but there is some evidence that it may-have a profile of pharmacological action different from that typical of hallucinogens in this series. No toxicological or pharmacokinetic data are available.
It is not self-administered by baboons. No data are available on its clinical abuse liability, on the nature or magnitude of associated public health or social problems, or on the epidemiology of its use or abuse. The drug is under national control in four countries. There is no known therapeutic use and no data on production. There is only one minor report of illicit trafficking. On the basis of the data outlined above, it was the consensus of the Expert Committee that 2,5-dimethoxy-4-ethylamphetamine met the criteria in article 2, paragraph 4, for control under the Convention on Psychotropic Substances. Since the substance has no therapeutic use, the Expert Committee recommended that it be placed in Schedule I of the Convention.
ECDD Recommendation
Inclusion in Schedule I of the 1971 Convention on Psychotropic Substances
Link to full TRS
who_trs_729.pdf1.29 MB